Deals this week: BioRap Technologies, Saniona AB, Mylan N.V

BioRap Technologies and Pfizer have entered a co-development agreement to improve the research and development of novel immunomodulators, which will help in introducing new treatment options for chronic autoimmune diseases.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news